CD4 and liver cancer: And a novel insight is that immunophenotypes of CD3 on naive CD8+ T cells and CD3 on naive CD4+ T cells were revealed as mediators of the association between anilides and the risk of liver cancer, which may be a potential molecular mechanism for PAU’s protective effect against liver cancer.